^○Kanako Hagio¹, Junko Kikuchi¹, Kohichi Takada², Hiroki Tanabe³, Minako Sugiyama^1,4, Yoshihito Ohhara^1,5, Toraji Amano^1,5, Satoshi Yuki⁶, Yoshito Komatsu⁷, Yutaka Hatanaka⁸, Ichiro Yabe⁹, Yoshihiro Matsuno¹⁰, Atsushi Manabe⁴, Akihiro Sakurai¹¹, Atsushi Ishiguro¹², Masato Takahashi¹³, Hirohito Naruse¹⁴, Yusuke Mizukami³, Hirotoshi Dosaka-Akita^1,5, Ichiro Kinoshita^1,5 (1.Division of Clinical Cancer Genomics, Hokkaido University Hospital, 2.Department of Medical Oncology, Sapporo Medical University School of Medicine, 3.Genetic Oncology Department, Asahikawa Medical University Hospital, 4.Department of Pediatrics, Hokkaido University Hospital, 5.Department of Medical Oncology, Hokkaido University Hospital, 6.Department of Gastroenterology and Hepatology, Hokkaido University Hospital, 7.Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, 8.Center for Development of Advanced Diagnostics, Hokkaido University Hospital, 9.Division of Clinical Genetics, Hokkaido University Hospital, 10.Department of Surgical Pathology, Hokkaido University Hospital, 11.Department of Medical Genetics and Genomics, Sapporo Medical University, 12.Department of Medical Oncology, Teine Keijinkai Hospital, 13.Department of Cancer Genome Medical Center, NHO Hokkaido Cancer Center, 14.Department of Gastroenterology, Hakodate Municipal Hospital)

^○Masachika Ikegami^1,2,3, Shinji Kohsaka², Tsuyoshi Hirose^2,4, Toshihide Ueno², Satoshi Inoue², Naoki Kanomata⁵, Hideko Yamauchi⁶, Taisuke Mori⁷, Shigeki Sekine⁷, Yoshihiro Inamoto⁸, Yasushi Yatabe^7,9, Hiroshi Kobayashi³, Sakae Tanaka³, Toru Akiyama¹⁰, Tomotake Okuma¹, Hiroyuki Mano² (1.Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 2.Division of Cellular Signaling, National Cancer Center Research Institute, 3.Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 4.Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 5.Department of Pathology, St Luke’s International Hospital, 6.Department of Breast Surgical Oncology, St Luke’s International Hospital, 7.Division of Molecular Pathology, National Cancer Center Research Institute, 8.Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 9.Department of Biobank and Tissue Resources, National Cancer Center Research Institute, 10.Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University)

^○Kei Kunimasa¹, Matsumoto Shingo², Nishino Kazumi¹, Honma Keiichiro³, Kuhara Hanako¹, Tamiya Motohiro¹, Inoue Takako¹, Kawamura Takahisa¹, Goto Koichi², Kumagai Toru¹ (1.Department of Thoracic Oncology, Osaka International Cancer Institute, 2.Department of Thoracic Oncology, National Cancer Center Hospital East, 3.Department of Diagnostic Pathology & Cytology, Osaka International Cancer Institute)

^○Naomi Hayashi¹, Ippei Fukada^1,3, Akihiro Ohmoto², Mari Hosonaga^1,3, Xiaofei Wang^1,2, Masumi Yamazaki^1,4, Arisa Ueki⁵, Kazuma Kiyotani⁶, Akiko Tonooka⁷, Kengo Takeuchi^7,8,9, Seiichi Mori¹⁰, Shunji Takahashi^1,2,4 (1.Genomic Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 2.Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3.Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 4.The Center for Advanced Medical Development, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 5.Clinical Genetic Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 6.Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 7.Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 8.Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 9.Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, 10.Division of Cancer Genomics, Japanese Foundation for Cancer Research, Cancer Institute)

^○Masahiro Yoshioka¹, Tomohiro Kondo¹, Quy Pham Nguyen², Reiko Kimura-Tsuchiya¹, Keita Fukuyama^1,3, Masashi Kanai¹, Takeshi Nakajima⁴, Takahiro Yamada⁴, Shigemi Matsumoto^1,3, Manabu Muto¹ (1.Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan, 2.Department of Clinical Oncology, Kyoto Min-iren Chuo Hospital, Kyoto, Japan, 3.Department of Real World Data R&D, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4.Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan)

^○Kayoko Kibata¹, Yasuhiro Koh², Jun Oyanagi², Satoru Miura³, Hiroshige Yoshioka¹, Koichi Azuma⁴, Hidenobu Ishii⁴, Shunsuke Teraoka², Kenichi Koyama³, Yuichi Ozawa², Takaaki Tokito⁴, Toshio Shimokawa⁵, Takayasu Kurata¹, Nobuyuki Yamamoto², Hiroshi Tanaka³ (1.Department of Thoracic Oncology, Kansai Medical University Hospital, 2.Internal Medicine III, Wakayama Medical University, 3.Department of Internal Medicine, Niigata Cancer Center Hospital, 4.Division of Respirology and Rheumatology, Department of Internal Medicine, 5.Center for Biomedical Sciences, Wakayama Medical University)